Ultragenyx Pharmaceutical Inc.

RARENasdaq· Pharmaceutical Preparations

Price History

Revenue

$673.0M

▲ 20.2% YoY

Net Income

-$575.0M

▼ 1.1% YoY

EPS

$-5.83

▲ 7.3% YoY

Cash

$421.0M

▲ 142.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.